Delivery Order SPE2DB20D3505-SPE2DB25FV0M6
- Not listed
- The Defense Logistics Agency awarded a $1,436.96 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Terbinafine HCL 250 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 22, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $42,212 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets in quantities of 100 units. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of July 28, 2025. The contract was executed on July 25, 2025, with performance to be conducted at the contractor's corporate office location in Conshohocken,...
- This is a $3,145.46 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of Terbinafine HCl 250 mg tablets, with a period of performance through July 9, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which enables...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $7,418.26, represents a non-competitive set-aside award and is scheduled for completion by July 21, 2025. The pharmaceutical product will be delivered to the prime contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $1,000.37 firm fixed price delivery order is for the supply of 90 tablet bottles of the medication Terbinafine Hydrochloride 250 mg. The contract has an ultimate completion date of July 17, 2025 and was competitively awarded without any set-aside designation. AmerisourceBergen...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,958.45 firm fixed-price contract is for the delivery of Terbinafine HCL 250 mg tablets. The contract has a completion date of July 8, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp also holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This delivery order, awarded July 21, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of Terbinafine HCL 250 mg tablets in quantities of 100 units, with a ceiling value of $11,615.45 and a completion date of July 22, 2025. The contract utilizes firm fixed pricing and is not designated as a set-aside award, indicating that it was competitively procured. Performance will be fulfilled from AmerisourceBergen Drug Corp's corporate office location in...
- The Defense Logistics Agency Troop Support Medical awarded a $4.05 million firm fixed price delivery order to Amerisourcebergen Drug Corp for terbinafine hydrochloride. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical to the agency from its facility in Conshohocken, Pennsylvania under a one day period of performance between August 1-2, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency supports the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,050.91, is for the delivery of Terbinafine HCL 250 mg tablets. The contract is a firm-fixed-price delivery order with a performance period ending on May 8, 2025. This order is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,163.16, is a Delivery Order for 4,566,761,020 units of Terbinafine HCL 250 mg tablets with a completion date of December 19, 2024. The contract is not designated under any set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FV0M6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,111.23 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (100 count) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive portfolio of DLA contracts encompasses a wide spectrum of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The contractor's demonstrated capability to compete successfully for federal medical supply requirements positions it as a key provider to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its flexible contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/25/25 |